The partners said a TROP2-targeting antibody drug conjugate succeeded in a late-stage trial, paving the way for potential ...
Itvisma, an intrathecal version of Zolgensma, can be used in children, teens and adults to stabilize or improve motor ...
The company, which invested heavily in oncology in recent years, has now put more than $400 million on the table to access a ...
Top executives can steer large pharma companies in many ways. Here are the ones who employees approve of the most.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback